"Oxymetazoline/pharmacology"[MeSH] - Search Results

Year	Number of Results
1967	1
1968	3
1969	4
1970	1
1971	2
1972	6
1973	7
1974	10
1975	12
1976	5
1977	5
1978	6
1979	15
1980	7
1981	7
1982	9
1983	16
1984	9
1985	18
1986	9
1987	13
1988	10
1989	11
1990	16
1991	18
1992	14
1993	18
1994	20
1995	26
1996	19
1997	14
1998	18
1999	21
2000	16
2001	10
2002	11
2003	13
2004	5
2005	11
2006	7
2007	11
2008	9
2009	6
2010	7
2011	8
2012	7
2013	8
2014	8
2015	8
2016	13
2017	9
2018	16
2019	10
2020	9
2021	8
2022	8
2023	9
2024	2

1

A Real-World Observational Study to Evaluate the Safety and Effectiveness of Fluticasone Furoate-Oxymetazoline Fixed Dose Combination Nasal Spray in Patients with Allergic Rhinitis.

Juvekar MR, Vaidya GK, Majumder A, Pendharkar AD, Irudhayarajan A, Kundu A, Ramesh D, Kumar JD, Jagannatha B, Mathew J, Nikam MP, Mehta M, Chawla N, Hajare P, Gowda PGC, Murthy PVLN, Mathew SM, Damle MV, Kant C, Nair AB, Jaiswal A, Mehta RT. Juvekar MR, et al. Clin Drug Investig. 2024 Feb;44(2):123-130. doi: 10.1007/s40261-023-01338-8. Epub 2024 Jan 9. Clin Drug Investig. 2024. PMID: 38195833

2

Nose-Ocomial Pulmonary Edema: A Rare Complication of Oxymetazoline.

Godbe KN, Sinik LM, Lemons DV, Sokol JA. Godbe KN, et al. Ophthalmic Plast Reconstr Surg. 2024 Mar-Apr 01;40(2):e35-e36. doi: 10.1097/IOP.0000000000002529. Epub 2023 Sep 18. Ophthalmic Plast Reconstr Surg. 2024. PMID: 37721321

3

Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment.

Zannikos P, Solanki B, De Meulder M, Badorrek P, Hohlfeld JM, Singh J. Zannikos P, et al. Clin Pharmacokinet. 2023 Sep;62(9):1315-1328. doi: 10.1007/s40262-023-01273-z. Epub 2023 Jul 4. Clin Pharmacokinet. 2023. PMID: 37402024 Clinical Trial.

4

Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta-analysis.

Liu F, Zhou Q, Wang H, Fu H, Li Y, Tao M, Luo H, Cao Y. Liu F, et al. J Cosmet Dermatol. 2023 Sep;22(9):2408-2419. doi: 10.1111/jocd.15747. Epub 2023 May 2. J Cosmet Dermatol. 2023. PMID: 37128814 Review.

5

The effects of topical oxymetazoline on eyelid position, eye redness, and patient-reported eye appearance: A randomized controlled trial.

Shoji MK, Markatia Z, Ameli K, Bayaraa M, Clauss KD, Ugradar S, Lee WW. Shoji MK, et al. J Plast Reconstr Aesthet Surg. 2023 May;80:66-74. doi: 10.1016/j.bjps.2023.02.006. Epub 2023 Feb 9. J Plast Reconstr Aesthet Surg. 2023. PMID: 36996503 Free article. Clinical Trial.

6

Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.

Carruthers J. Carruthers J. Aesthet Surg J. 2023 Aug 17;43(9):962-963. doi: 10.1093/asj/sjad076. Aesthet Surg J. 2023. PMID: 36978211 No abstract available.

7

Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.

Bernardini FP, Skippen B, Croasdell B, Cerón Bohórquez JM, Murray G, Sayed K, Walker L, Hartstein ME; Complications in Medical Aesthetics Collaborative (CMAC) Study Group. Bernardini FP, et al. Aesthet Surg J. 2023 Aug 17;43(9):955-961. doi: 10.1093/asj/sjad070. Aesthet Surg J. 2023. PMID: 36943792

8

The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post-acne erythema: A split-face, double-blind, randomized, placebo-controlled trial.

Washrawirul C, Puaratana-Arunkon T, Chongpison Y, Noppakun N, Asawanonda P, Kumtornrut C. Washrawirul C, et al. J Dermatol. 2023 Jun;50(6):739-745. doi: 10.1111/1346-8138.16749. Epub 2023 Feb 20. J Dermatol. 2023. PMID: 36806298 Clinical Trial.

9

Naphazoline and oxymetazoline are superior to epinephrine in enhancing the cutaneous analgesia of lidocaine in rats.

Chou AK, Chiu CC, Zhu GC, Wang JJ, Chen YW, Hung CH. Chou AK, et al. Fundam Clin Pharmacol. 2023 Apr;37(2):296-304. doi: 10.1111/fcp.12853. Epub 2022 Nov 28. Fundam Clin Pharmacol. 2023. PMID: 36394965

10

Benefits and safety of Oxymetazoline cream 1% on rosacea-associated erythema: A systematic review and analysis of clinical evidence.

Yuan X, Yin D. Yuan X, et al. J Cosmet Dermatol. 2023 Jan;22(1):103-110. doi: 10.1111/jocd.15467. Epub 2022 Oct 24. J Cosmet Dermatol. 2023. PMID: 36237138 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

572 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

572 results

Results by year